Literature DB >> 16287998

Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.

Hidetaka A Ono1, Long P Le, Julia G Davydova, Tatyana Gavrikova, Masato Yamamoto.   

Abstract

To overcome the inefficacy and undesirable side effects of current cancer treatment strategies, conditionally replicative adenoviruses have been developed to exploit the unique mechanism of oncolysis afforded by tumor-specific viral replication. Despite rapid translation into clinical trials and the established safety of oncolytic adenoviruses, the in vivo function of these agents is not well understood due to lack of a noninvasive detection system for adenovirus replication. To address this issue, we propose the expression of a reporter from the adenovirus E3 region as a means to monitor replication. Adenovirus replication reporter vectors were constructed with the enhanced green fluorescent protein (EGFP) gene placed in the deleted E3 region under the control of the adenoviral major late promoter while retaining expression of the adenovirus death protein to conserve the native oncolytic capability of the virus. Strong EGFP fluorescence was detected from these vectors in a replication-dependent manner, which correlated with viral DNA replication. Fluorescence imaging in vivo confirmed the ability to noninvasively detect fluorescent signal during replication, which generally corresponded with the underlying level of viral DNA replication. EGFP representation of viral replication was further confirmed by Western blot comparison with the viral DNA content in the tumors. Imaging reporter expression controlled by the adenoviral major late promoter provides a viable approach to noninvasively monitor adenovirus replication in preclinical studies and has the potential for human application with clinically relevant imaging reporters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287998     DOI: 10.1158/0008-5472.CAN-05-1871

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

Review 1.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

2.  A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.

Authors:  Ronald Rodriguez; Shawn E Lupold; Ping Wu; Lori J Sokoll; Tarana A Kudrolli; Wasim H Chowdhury; Rong Ma; Minzhi M Liu
Journal:  Prostate       Date:  2014-07-25       Impact factor: 4.104

3.  Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy.

Authors:  Leonard Armstrong; Amanda Arrington; Joohee Han; Tatyana Gavrikova; Eric Brown; Masato Yamamoto; Selwyn M Vickers; Julia Davydova
Journal:  Am J Surg       Date:  2012-06-29       Impact factor: 2.565

4.  Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.

Authors:  Leonard Armstrong; Julia Davydova; Eric Brown; Joohee Han; Masato Yamamoto; Selwyn M Vickers
Journal:  Surgery       Date:  2012-04-11       Impact factor: 3.982

5.  Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

Authors:  Christopher J LaRocca; Joohee Han; Tatyana Gavrikova; Leonard Armstrong; Amanda R Oliveira; Ryan Shanley; Selwyn M Vickers; Masato Yamamoto; Julia Davydova
Journal:  Surgery       Date:  2015-02-27       Impact factor: 3.982

6.  Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy.

Authors:  Michael J Oneal; Miguel A Trujillo; Julia Davydova; Samantha McDonough; Masato Yamamoto; John C Morris
Journal:  Hum Gene Ther       Date:  2012-08-22       Impact factor: 5.695

7.  Conditionally replicative adenoviral vectors for imaging the effect of chemotherapy on pancreatic cancer cells.

Authors:  Jun Kimura; Hidetaka A Ono; Takashi Kosaka; Yoji Nagashima; Shuichi Hirai; Shigeo Ohno; Kazunori Aoki; Davydova Julia; Masato Yamamoto; Chikara Kunisaki; Itaru Endo
Journal:  Cancer Sci       Date:  2013-07-03       Impact factor: 6.716

Review 8.  Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.

Authors:  Dirk M Nettelbeck
Journal:  J Mol Med (Berl)       Date:  2007-12-19       Impact factor: 4.599

9.  Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.

Authors:  Kristopher J Kimball; Angel A Rivera; Kurt R Zinn; Mert Icyuz; Vaibhav Saini; Jing Li; Zeng B Zhu; Gene P Siegal; Joanne T Douglas; David T Curiel; Ronald D Alvarez; Anton V Borovjagin
Journal:  Mol Imaging       Date:  2009 Sep-Oct       Impact factor: 4.488

10.  Evaluation of adenovirus capsid labeling versus transgene expression.

Authors:  Jing Li; Aiman Fatima; Svetlana Komarova; Hideyo Ugai; Priyanka Uprety; Justin C Roth; Minghui Wang; Robert A Oster; David T Curiel; Qiana L Matthews
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.